These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7967709)
1. Principal drug-metabolizing enzyme systems in L1210 leukemia sensitive or resistant to BCNU in vivo. Ribrag V; Massaad L; Janot F; Bissery MC; Parise O; Gouyette A; Chabot GG Leuk Res; 1994 Nov; 18(11):829-35. PubMed ID: 7967709 [TBL] [Abstract][Full Text] [Related]
2. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635 [TBL] [Abstract][Full Text] [Related]
3. Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38. Massaad L; Chabot GG; Toussaint C; Koscielny S; Morizet J; Bissery MC; Gouyette A Cancer Chemother Pharmacol; 1994; 34(6):497-502. PubMed ID: 7923560 [TBL] [Abstract][Full Text] [Related]
4. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260 [TBL] [Abstract][Full Text] [Related]
5. Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma. Janot F; Massaad L; Ribrag V; de Waziers I; Beaune PH; Luboinski B; Parise O; Gouyette A; Chabot GG Carcinogenesis; 1993 Jul; 14(7):1279-83. PubMed ID: 8330340 [TBL] [Abstract][Full Text] [Related]
6. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Massaad L; de Waziers I; Ribrag V; Janot F; Beaune PH; Morizet J; Gouyette A; Chabot GG Cancer Res; 1992 Dec; 52(23):6567-75. PubMed ID: 1423302 [TBL] [Abstract][Full Text] [Related]
7. [Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors]. Massaad L; de Waziers I; Ribrag V; Janot F; Morizet J; Beaune PH; Gouyette A; Chabot GG Bull Cancer; 1993 May; 80(5):397-407. PubMed ID: 8173193 [TBL] [Abstract][Full Text] [Related]
8. Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy. Ribrag V; Massaad L; Janot F; Morizet J; Gouyette A; Chabot GG Leuk Lymphoma; 1995 Jul; 18(3-4):303-10. PubMed ID: 8535197 [TBL] [Abstract][Full Text] [Related]
9. Severe depletion of cellular thiols and glutathione-related enzymes of a carmustine-resistant L1210 strain associates with collateral sensitivity to cyclophosphamide. Institoris E; Tretter L; Gaál D Cancer Chemother Pharmacol; 1993; 33(1):85-8. PubMed ID: 8269595 [TBL] [Abstract][Full Text] [Related]
10. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver. el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821 [TBL] [Abstract][Full Text] [Related]
11. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. Ali-Osman F; Stein DE; Renwick A Cancer Res; 1990 Nov; 50(21):6976-80. PubMed ID: 2208164 [TBL] [Abstract][Full Text] [Related]
12. In vivo DNA damage and resistance to 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in L1210 leukemia cells. Gorbacheva LB; Kukushkina GV; Durdeva AD; Ponomarenko NA Neoplasma; 1988; 35(1):3-14. PubMed ID: 3127736 [TBL] [Abstract][Full Text] [Related]
13. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo]. Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985 [TBL] [Abstract][Full Text] [Related]
14. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Smith MT; Evans CG; Doane-Setzer P; Castro VM; Tahir MK; Mannervik B Cancer Res; 1989 May; 49(10):2621-5. PubMed ID: 2713846 [TBL] [Abstract][Full Text] [Related]
15. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968 [TBL] [Abstract][Full Text] [Related]
16. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases. Weber GF; Waxman DJ Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024 [TBL] [Abstract][Full Text] [Related]
17. Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea. McConnell WR; Kari P; Hill DL Cancer Chemother Pharmacol; 1979; 2(3):221-3. PubMed ID: 455578 [TBL] [Abstract][Full Text] [Related]
18. [The role of N-nitrosourea-induced changes in the nucleoid structure and activity of repair enzymes in the development of drug resistance in mice with leukemia L1210]. Durdyeva ED; Ponomarenko NA; Kukushkina GV; Gorbacheva LB Biokhimiia; 1987 Aug; 52(8):1335-43. PubMed ID: 3663767 [TBL] [Abstract][Full Text] [Related]
19. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834 [TBL] [Abstract][Full Text] [Related]
20. Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line. Berhane K; Hao XY; Egyházi S; Hansson J; Ringborg U; Mannervik B Cancer Res; 1993 Sep; 53(18):4257-61. PubMed ID: 8395980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]